- Home
- XGN vs SSSS Comparison
XGN vs SSSS Comparison
Compare XGN & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- SSSS
- Stock Information
- Founded
- XGN 2002
- SSSS 2010
- Country
- XGN United States
- SSSS United States
- Employees
- XGN N/A
- SSSS N/A
- Industry
- XGN Medical Specialities
- SSSS Finance: Consumer Services
- Sector
- XGN Health Care
- SSSS Finance
- Exchange
- XGN Nasdaq
- SSSS Nasdaq
- Market Cap
- XGN 138.3M
- SSSS 138.2M
- IPO Year
- XGN 2019
- SSSS N/A
- Fundamental
- Price
- XGN $6.84
- SSSS $6.44
- Analyst Decision
- XGN Strong Buy
- SSSS Buy
- Analyst Count
- XGN 2
- SSSS 2
- Target Price
- XGN $7.50
- SSSS $8.00
- AVG Volume (30 Days)
- XGN 374.9K
- SSSS 197.4K
- Earning Date
- XGN 05-05-2025
- SSSS 05-06-2025
- Dividend Yield
- XGN N/A
- SSSS N/A
- EPS Growth
- XGN N/A
- SSSS N/A
- EPS
- XGN N/A
- SSSS N/A
- Revenue
- XGN $56,724,000.00
- SSSS $3,644,430.00
- Revenue This Year
- XGN $19.39
- SSSS $6.95
- Revenue Next Year
- XGN $13.27
- SSSS N/A
- P/E Ratio
- XGN N/A
- SSSS N/A
- Revenue Growth
- XGN 1.78
- SSSS N/A
- 52 Week Low
- XGN $1.71
- SSSS $3.52
- 52 Week High
- XGN $7.20
- SSSS $6.83
- Technical
- Relative Strength Index (RSI)
- XGN 62.02
- SSSS 67.18
- Support Level
- XGN $6.51
- SSSS $6.16
- Resistance Level
- XGN $7.20
- SSSS $6.77
- Average True Range (ATR)
- XGN 0.51
- SSSS 0.33
- MACD
- XGN 0.04
- SSSS 0.03
- Stochastic Oscillator
- XGN 81.15
- SSSS 71.30
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.